M
MMI
A developer of novel robotic solutions for unmet medical needs for microsurgery, with a teleoperated robotic platform for suturing in open surgery with wristed microinstruments
About MMI
MMI (Medical Microinstruments) is an Italian-American medtech company developing the Symani Surgical System, a teleoperated robotic platform with wristed microinstruments designed for microsurgery and supermicrosurgery on structures as small as about 0.1 mm, including lymphatic repair for lymphedema and complex reconstructive procedures. The company sells systems and related services to hospitals and surgical centres under a B2B model and continues clinical and commercial expansion in Europe and the United States. In September 2026 Angelini Ventures and the European Investment Bank co-invested €17 million in MMI as the third deal under their €150 million partnership (bringing partnership commitments to about €68.5 million), to advance Symani commercialisation and clinical development. Sources: Angelini Ventures 16 Sep 2026; EIB / GlobeNewswire; Il Sole 24 Ore.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- Pisa, Italy
- Employees
- 339
- Open positions
- 4
- Dealroom signal
- 76.6/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Mechanical Solutions, Surgery, Medical Robots, Surgical Equipment, Tech for Hospitals and Clinics, Tech for Medical Professionals, Collaborative Robots, Physician Support Tools
- Technology
- Hardware, Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES COther financing | Feb 2024 | $110M | $440M | Fidelity Investments · Panakès Partners · Deerfield · RA Capital Management | ↗ |
| SERIES BOther financing | Jul 2022 | $75M | $300M | RA Capital Management · Andera Partners · Fountain Healthcare Partners · Panakès Partners | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for MMI is 9.9K monthly website visits, down 10% over the last three months. MMI's team declined 0.3% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A7 investors entered at this stage
Fountain Healthcare Partners
Panakès Partners
Andera Partners- SSSambatech Srl
Deerfield
RA Capital Management
BioStar Capital
Series B and later2 investors entered at this stage
European Investment Bank
Fidelity Investments
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about MMI on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See MMI’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.